(19)
(11) EP 2 297 206 A1

(12)

(43) Date of publication:
23.03.2011 Bulletin 2011/12

(21) Application number: 09747210.4

(22) Date of filing: 07.05.2009
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 35/00(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2009/043063
(87) International publication number:
WO 2009/140124 (19.11.2009 Gazette 2009/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 14.05.2008 US 53192 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, IN 46285 (US)

(72) Inventors:
  • DICKERSON, Cindy, Takeuchi
    Indianapolis, IN 46285 (US)
  • MARQUIS, David, Matthew
    Encitas CA 92024 (US)
  • OBUNGU, Victor
    Indianapolis, IN 46285 (US)
  • PENG, Sheng-Bin
    Indianapolis, IN 46285 (US)
  • VAILLANCOURT, Peter, Edward
    Indianapolis, IN 46285 (US)

(74) Representative: Commander, Paul Martin Brial et al
Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) ANTI-CXCR4 ANTIBODIES